% Expired Patents = 75.0

EPO Patents = 1

Forward Citations = 4

Loading Chart...

12 inventors (with patents filed for the assignee):

Giancarlo Tonon (4 out of 6 patents)

Gaetano Orsini (4 out of 7 patents)

Mauro Sergi (2 out of 2 patents)

4. Rodolfo Schrepfer (2 out of 2 patents)

5. Geoffrey Taylor (2 out of 3 patents)

6. Pierandrea Esposito (1 out of 3 patents)

7. Simona Cali (1 out of 1 patent)

8. Daniela Ghisotti (1 out of 2 patents)

9. Giuseppina Bestetti (1 out of 2 patents)

10. Gabriele Zuffi (1 out of 2 patents)

11. Marco Vanoni (1 out of 2 patents)

12. Paolo Tortora (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 8580733 - Site-specific monoconjugated insulinotropic GLP-1 peptides (2013-11-12),

2. 7893019 - G-CSF site-specific mono-conjugates (2011-02-22),

3. 7781189 - Catalyzing transglycosylation using a recombinant host cell overexpressing uridine phosphorylase and purine nucleoside phosphorylase (2010-08-24),

4. 7410775 - Method for making recombinant peptides or proteins using soluble endoproteases (2008-08-12),

Company Overview

Bio-ker Srl is a leading biotechnology company specializing in the development and production of innovative biomaterials for medical and cosmetic applications. With a strong focus on research and development, Bio-ker is committed to bringing cutting-edge solutions to market that improve patient outcomes and drive growth in the healthcare industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#346 in Milan

#1,957 in Italy

Milan, Italy

Bio-Ker Srl

Forward Citations = 4

12 inventors:

Giancarlo Tonon (4 out of 6 patents)

Gaetano Orsini (4 out of 7 patents)

Mauro Sergi (2 out of 2 patents)

4. Rodolfo Schrepfer (2 out of 2 patents)

5. Geoffrey Taylor (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bio-Ker Srl. Retrieved from https://idiyas.com/company/bio-ker-srl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]